Skip to main content

Advertisement

Table 1 Characteristics of included studies

From: Fish oil administration in older adults: is there potential for adverse events? A systematic review of the literature

Author, year Mean age (y) n-3 dosage (EPA/DHA) Control/placebo Duration Sample size ( n) Method of administration
Rondanelli et al. 2010 [40] 84.9 1.67 g/d EPA; 0.83 g/d DHA Paraffin oil 8 weeks 46 Liquid
a Bechoua et al. 2003 [29] 75.6 30 mg/d EPA 150 mg/d DHA Sunflower oil 6 weeks 20 Capsules
b Vericel et al. 1999 [30]       
Gruenwald et al. 2009 [42] 62.3 0.6 g/d EPA/DHA Glucosamine sulfate 26 weeks 177 Capsules
a Van de Rest et al. 2009 [36] 69.8 1.8 g/d EPA/DHA (high-dose); OR 0.4 g/d EPA/DHA (low dose) High-oleic sunflower oil 26 weeks 302 Capsules
b Bouwens et al. 2009 [39]       
c Van de Rest et al. 2008 [37]       
d Van de Rest et al. 2008 [38]       
Querques et al. 2009 [41] 72.7 0.72 g/d EPA; 0.48 g/d DHA Usual care 26 weeks 38 Unclear
a Thies et al. 2001 [31] 55-75 0.7 g/d DHA; OR 0.72 g/d EPA; 0.28 g/d DHA α-linolenic acid, γ-linolenic acid, OR arachidonic acid 12 weeks 46 Capsules
b Thies et al. 2001 [32]       
a Vedin et al. 2010 [33] 74 0.6 g/d EPA; 1.72 g/d DHA Corn oil 52 weeks 174 Capsules
b Vedin et al. 2008 [34]       
c Freund-Levi et al. 2006 [35]       
Smith et al. 2011 [45] 71 1.86 g/d EPA; 1.5 g/d DHA Corn oil 8 weeks 15 Capsules
Fakhrzadeh et al. 2010 [43] 74.8 180 mg/d EPA; 120 mg/d DHA   26 weeks 124 Capsules
Holguin et al. 2005 [44] 76.5 2 g/d total marine triglycerides; each 1 g containing 83.2% EPA/DHA Soy oil 26 weeks 52 Capsules
  1. Studies identified by superscripted numbers refer to those derived from the same trial and population sample and are therefore treated as a single publication source for the purposes of this review.